Cuba vs Niger: Access to anti-retroviral drugs, female
Cuba
78.0%
in 2024
Niger
79.0%
in 2024
Cuba rank
60th
Niger rank
59th
Access to anti-retroviral drugs, female over time
- Cuba
- Niger
How they compare
Niger currently reports 79.0% against 78.0% in Cuba, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Cuba ahead.
Cuba ranks 60th and Niger ranks 59th of 141 countries.
Across the 3 decades both report, Cuba averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Cuba | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.0% | 5.0% | 9.0% | Cuba |
| 2010s | 50.9% | 54.5% | 3.6% | Niger |
| 2020s | 76.2% | 83.2% | 7.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cuba or Niger?
- Niger, at 79.0% against 78.0% in Cuba as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cuba and Niger?
- 1.0%, with Niger ahead.
- How many years of comparable data are there for Cuba and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Cuba and Niger rank globally for access to anti-retroviral drugs, female?
- Cuba ranks 60th and Niger ranks 59th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.